SCHEMBL8909720

SCHEMBL8909720

CC1=C(C(=O)OCc2ccccc2)N=c2cc3c(c(C)c21)=Nc1ccc(F)cc1-3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.38
KMT2A Q03164 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
PKM P14618 1/20 0.36
MAPT P10636 7/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
RAB9A P51151 5/20 0.35
NPC1 O15118 2/20 0.35
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
KDM4E B2RXH2 3/20 0.34
STAT1 P42224 2/20 0.34
GAA P10253 1/20 0.34
PPARG P37231 1/20 0.34
AR P10275 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910758 0.92 DHODH (0.38) DHODHKMT2ATDP1SLC6A2SLC6A3
SCHEMBL1388713 0.89 TDP1 (0.40) KMT2ATDP1SLC6A2SLC6A3MAPT
SCHEMBL8909595 0.89 DHODH (0.38) DHODHKMT2ATDP1SLC6A2SLC6A3
SCHEMBL8909809 0.88 TSHR (0.37) KMT2AMAPTL3MBTL1RAB9ANPC1
SCHEMBL8909637 0.88 TDP1 (0.40) DHODHKMT2ATDP1SLC6A2SLC6A3
SCHEMBL8365325 0.82 ABL1 (0.32) PPARG
SCHEMBL8911173 0.81 TDP1 (0.39) KMT2ATDP1SLC6A2SLC6A3MAPT
SCHEMBL8909629 0.79 CA12 (0.39) KMT2ATDP1MAPTLMNAALDH1A1
SCHEMBL9434331 0.76 TDP1 (0.36) DHODHKMT2ATDP1SLC6A2SLC6A3
SCHEMBL8150300 0.76 MAPK1 (0.33) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US claimed
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed